Drugs / Allogeneic Cluster of Differentiation 8 (CD8)+ Memory T-cells
Allogeneic Cluster of Differentiation 8 (CD8)+ Memory T-cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02424968 | Jun 2015 → Jul 2020 | B-cell chronic lymphocytic leukemia, Hodgkins lymphoma, T-cell non-Hodgkin lymphoma, acute myeloid leukemia +1 | Robert Lowsky | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Cluster of Differentiation 8 (CD8)+ Memory T-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02424968 ↗ |
| Modality | Cell therapy | “Giving an infusion of the donor's white blood cells, such as CD8+ memory T-cells” NCT02424968 ↗ |
| Route | Intravenous | “Receive CD8+ memory T-cells via IV” NCT02424968 ↗ |